Fifty patients whose sera contained a speckled antinuclear antibody (ANA) were interviewed and examined to determine if there was any relationship between their clinical manifestations and the presence of certain serological markers. The results suggest that speckled ANA is usually found in patients with definite connective tissue diseases, but a significant minority have incomplete or early stages of these diseases. Characterisation of the antibody to extractable nuclear antigen (ENA) and other serological markers does not normally assist in making a clinical diagnosis, but the detection of a speckled ANA should prompt further investigation and careful follow up.
INTRODUCTION
Autoantibodies to nuclear antigens can be detected in a variety of ways. Immunofluorescent staining of tissue specimens and cultured cells can reveal antibodies reactive with nuclear components and various patterns of staining, i.e. homogeneous, nucleolar, speckled-patterns have been identified and found to be diagnostically useful. In addition immunochemical tests using antigens extracted from cell nuclei (extractable nuclear antigens; ENA) can be used to identify a number of these antinuclear antibodies. A number of groups have reported the clinical significance of antibodies to extractable nuclear antigens (ENA), but these studies have generally been carried out on highly selected groups of patients drawn from specialist clinics. 1 2, 3 This selection tends to introduce a bias in favour of the speciality concerned. In an attempt to overcome this problem, we have examined the clinical and laboratory features of patients whose sera were received in a routine diagnostic immunology laboratory and gave a speckled antinuclear antibody staining pattern at a titre of one in 80 or greater, when tested by indirect immunofluorescence.
MATERIALS AND METHODS

Patients
Fifty consecutive patients on whom data were complete and who had significant titres of speckled antinuclear antibody (ANA) were selected for study. Of these 50 patients, 42 were female and eight male with a mean age of 45 years (range: 15 to 87 years). The duration of disease symptoms was between two and 31 years. Each patient was reviewed in person by a clinician (ACF, JDMcC or AJT) who completed a detailed questionnaire recording the time and nature of the onset of clinical symptoms and the course of the illness. Patients were examined for signs of disease with particular reference to the locomotor system and connective tissues. Systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS) and rheumatoid arthritis (RA) were all diagnosed according to criteria of the American Rheumatism Association (ARA).4, 5'6 The results of all previous investigations were recorded and a blood sample was taken for estimation of antibodies to double-stranded deoxyribonucleic acid (ds DNA), single-stranded deoxyribonucleic acid (ss DNA), histone, centromere, cardiolipin and extractable nuclear antigens (ENA). Rheumatoid factor (RF), complement components C3 and C4, immunoglobulins G, A and M were also measured.
Laboratory methods Antibodies giving a characteristic speckled ANA pattern were detected by indirect immunofluorescence using 5 pm cryostat sections of rat composite tissue as substrate and fluorescein conjugated rabbit immunoglobulin to human kappa and lambda chains. The titres of antibodies in individual G and M immunoglobulin classes were determined using both fluorescein conjugated rabbit immunoglobulins to human IgG and IgM. Antibodies to extractable nuclear antigens (anti-ribonucleoprotein, -Sm, -Ro and -La) were detected and identified using counterimmunoelectrophoresis (CIE) and various saline cellular extracts as previously described." 2' 7, 8 Antibody levels to double-stranded (ds) DNA were assayed using the Farr technique and a level of ds DNA antibody activity greater than 25 units/ml was considered as a positive result. Antibody to denatured single-stranded (ss) DNA was detected by CIE.9 Anticentromere antibody was detected by indirect immunofluorescence using HEp 2 cultured cells as antigen.'0 Positive reference sera for antibodies to extractable nuclear antigens (ENA), ds DNA and centromere were obtained from the Centers for Disease Control, Atlanta, Georgia, USA. Antibody to histones was determined using indirect immunofluorescence and an acid-extraction histonereconstitution assay." Rheumatoid factor (RF) was assayed using the differential agglutination test12 employing rabbit IgG as antigen and a quantitative latex assay which employed human IgG as antigen. The WHO International Reference preparation for rheumatoid factors was employed and a level of 30 IU/ml or greater was considered positive for this study. Antibody to cardiolipin was determined by a positive reaction against the Venereal Disease Research
The Ulster Medical Journal Laboratory (VDRL) antigen with an accompanying negative reaction with the fluorescent treponemal antibody absorption test (FTA-ABS). Measurements of immunoglobulins G, A and M and complement C3 and C4 were assayed by laser nephelometry using internal standards (Beckman, UK). Statistical analysis Clinical and laboratory data were analysed using the 'Statistical Package for the Social Sciences' on a Vax computer at the Queen's University of Belfast. The statistical methods applied were the chi-squared test, the independent t-test and its non-parametric equivalent, the Mann-Whitney U test.
RESULTS
The majority of patients in the study group (40%) were diagnosed as systemic lupus erythematosus (SLE) with progressive systemic sclerosis (PSS) as the second most common diagnosis (18%). Patients with other connective tissue disorders comprised a further 22% of the total. The remainder (20%) had miscellaneous disorders, which included pulmonary fibrosis (with and without systemic hypertension), thrombocytopenic purpura, haemolytic anaemia and a bleeding tendency. Two patients had hypergammaglobulinaemia (IgG) and one had systemic hypertension ( Table 1) . None of these patients was on any Statistical findings In view of the large number of possible associations of clinical features and serum markers, a comprehensive listing of these is not given -most were not significant.
The UJlster Medical Journal
Some of the more positive associations are shown in Table II1 . If values below the 1 % level are considered to be clinically significant, then only xerostomia and the presence of an LE skin r4sh were significantly associated with particular
antibodies. There was no significant association between the presence of antibody to RNP and Raynaud's phenomenon or the presence of antibodies to Sm antigen and renal or central nervous system disease. The attempt to find statistically significant associations between clinical features and serological markers proved fruitless. Only xerostomia and a discoid LE skin rash were significantly associated with particular antibodies and these are unlikely to be of practical value. Despite this, our study demonstrates that the vast majority of patients with a speckled ANA do have significant disease and that the detection of this serological marker should prompt further investigation.
